What Trudeau Institute does

Trudeau Institute is a 140-year-old nonprofit biomedical research organization headquartered in Saranac Lake, New York, conducting immunology and infectious disease research focused on tuberculosis, influenza, dengue/Zika, and emerging pathogens. Its technical platform includes one of New York State's few Biosafety Level 3 (BSL-3) containment laboratories, specialized in vivo preclinical mouse and marmoset models, advanced core facilities for flow cytometry, confocal microscopy (Leica SP5), and ultra-high performance liquid chromatography–mass spectrometry (Agilent 6545 Q-TOF), as well as a computational chemogenomics platform for novel antimicrobial drug discovery.

The institute monetizes through a hybrid model. Its wholly-owned contract research subsidiary, TICRO Bioservices (established 2009), provides fee-for-service preclinical infectious disease and immunology research to pharmaceutical, academic, and government clients, including six of the world's 20 largest pharmaceutical companies for vaccine and anti-infective evaluation. The parent organization is funded primarily through competitive federal research grants from the NIH (R01, R21, SBIR mechanisms), foundation grants (Bill & Melinda Gates Foundation), congressionally directed federal appropriations for infrastructure, DASNY state grants, and donations from individuals and regional businesses.

The institute also operates educational pipelines, including the Summer Undergraduate Research Program, the Biomedical Research Scholars Program (Trudeau Semester), and high school science initiatives, and hosts annual scientific convenings such as the Ralph M. Steinman Memorial Lecture and the Northeast Regional World TB Day Conference. Leadership transitioned to William W. Reiley, Ph.D., in January 2024, during which time TICRO employment has tripled and the institute has secured over $13 million in new grants and congressionally directed funding across 2024-2026.

Name

Trudeau Institute

Legal name

Trudeau Institute, Inc.

Website

https://trudeauinstitute.org

Company type

Private

Founded year

1884

Operating status

Operating

Headcount range

101–250 employees

Short description

Trudeau Institute is a nonprofit biomedical research organization founded in 1884 in Saranac Lake, NY, conducting immunology and infectious disease research on tuberculosis, influenza, and dengue/Zika, with a wholly-owned CRO subsidiary (TICRO Bioservices) serving major pharmaceutical clients.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Tuberculosis & Mycobacterial Diseases (HLAKAGAH), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Infectious Disease POCT (Respiratory, STI, HIV, Sepsis) (HLAHAOAA)

Keywords

• Infectious disease research
• Immunology research services
• Preclinical contract research
• Tuberculosis research
• Vaccine development

Headquarters

HQ city

Saranac Lake

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain

Revenue model

1. TICRO Bioservices Contract Research: Fee-for-service contract research organization providing preclinical infectious disease and immunology research models. TICRO collaborates with external customers including pharmaceutical companies, academic institutions, and government agencies to develop custom research solutions for animal model development, drug testing, and evaluation of vaccines and therapeutics.
2. NIH Research Grants: Competitive federal research grants from National Institutes of Health including R01 and R21 mechanisms for TB drug discovery, SBIR grants for infectious disease research tools, and congressionally directed federal funding for infrastructure and workforce development.
3. Foundation Grants: Funding from foundations such as the Bill & Melinda Gates Foundation for global health research including TB treatment studies
4. Donations and Community Support: Direct financial contributions from donors supporting infectious disease research and community health initiatives

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Trudeau Institute is a nonprofit biomedical research organization conducting foundational and translational research in immunology and infectious disease, focusing on pathogens including tuberculosis, influenza, dengue/Zika viruses, and emerging drug-resistant pathogens. Through its wholly owned subsidiary TICRO Bioservices, it provides preclinical contract research services—including animal model development, drug testing, and vaccine/therapeutic evaluation—to pharmaceutical, academic, and government clients.

Product overview

Trudeau Institute is a not-for-profit biomedical research organization offering a unified portfolio of research programs, contract research services, and educational programs. The core offering consists of infectious disease and immunology research spanning tuberculosis, influenza, dengue/Zika, and emerging pathogens, supported by specialized core facilities (Histology/Imaging, Mass Spectrometry, Flow Cytometry). TICRO Bioservices provides contract preclinical research services to external clients. Educational programs include the semester-long Biomedical Research Scholars Program and the 10-week Summer Undergraduate Research Program.

Differentiator

Problem solved

Functional benefit

Brands

• TICRO Bioservices: Specialty contract research organization (CRO) focused on preclinical infectious disease and immunology research models, providing services to external academic, government, and industry partners.

Products and services

• TICRO Bioservices Specialty contract research organization (CRO) providing preclinical infectious disease and immunology research models, animal model development, drug testing, and evaluation of vaccines and therapeutics for external academic, government, and industry partners. Six of the world's 20 largest pharmaceutical companies are among its clients.
• Summer Undergraduate Research Program (SURP)

Quantifiable outcome

• 6 of world's 20 largest pharmaceutical companies are TICRO clients
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered major, core and community.

• SUNY Upstate Medical UniversitymajorStrategic or Co-development Partner · 20 October 2022Co-host of the 2022 Lyme & Tick-Borne Disease Summit in Saranac Lake, NY. Partnership bringing together frontline healthcare workers for educational seminars on tick-borne diseases.
• Ampersand BiosciencescoreStrategic or Co-development PartnerLong-standing collaboration since 2020 developing reagents for studying respiratory infections in animal models. Partners have secured over $2.8 million in federal SBIR funding including a fourth NIH award for $600,000 to develop monoclonal antibodies to chemokines in ferret models. Dr. Deb Brown at Trudeau leads research while Ampersand commercializes resulting products worldwide.
• Purdue UniversitymajorStrategic or Co-development PartnerCollaborator on NIH R01 grant for TI-374 small molecule development. Purdue partners with Dr. Chojnacki's lab at Trudeau Institute to advance first-in-class therapeutic strategies against drug-resistant Mycobacterium tuberculosis.
• Virginia TechmajorStrategic or Co-development PartnerCollaborator on NIH R21 grant for TI-507 molecule research. Partnership with Dr. Webster Santos at Virginia Tech focuses on determining molecular targets and optimizing the molecule for improved potency against TB persisters.
• Texas Biomedical Research InstitutecoreStrategic or Co-development PartnerCollaboration on Zika and dengue virus research using marmoset models. Research team led by Drs. Marcia Blackman and In-Jeong Kim at Trudeau worked with Texas Biomed researchers to study antibody-dependent enhancement and vertical virus transmission.
• Adirondack Medical CentercommunityStrategic or Co-development PartnerCOVID-19 response partnership during the pandemic. Part of Trudeau Institute's commitment to community health and the Adirondack region's economic vitality.
• Bionique Testing LaboratoriescommunityStrategic or Co-development PartnerRegional biotechnology company collaborating to strengthen the North Country life sciences industry. Bionique is building a 32,000-square-foot expansion in the Harrietstown Business Park and co-sponsored a biotech cluster growth event at Trudeau Institute.
• UCLAcoreStrategic or Co-development PartnerCollaborative research with Drs. Blackman and Sun on understanding how prior infections impact immune response to vaccination and subsequent infections, particularly for influenza virus and live-attenuated vaccines.
• Albert Einstein College of MedicinecoreStrategic or Co-development PartnerDr. Brian Weinrick holds an associate position at Albert Einstein College of Medicine. Collaboration involves Dr. William R. Jacobs Jr.'s laboratory for mycobacterial research using genomic, transcriptomic, and metabolomic approaches.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Taconic Biosciences: Privately held biotechnology company specializing in genetically engineered mouse models and related research services, headquartered in the New York Capital Region and Hudson Valley. Trudeau COO Alexander Maue previously led Taconic's Microbiome Strategic Initiative, and the organizations are geographically proximate in the North Country/Capital District NY life sciences ecosystem.

Broad incumbents

• Salk Institute for Biological Studies: Large, prestigious independent nonprofit biomedical research institute in La Jolla, California with broad research portfolio across immunology, neuroscience, and plant biology. Comparable as an independent nonprofit research institution with NIH grant dependence, though significantly larger and broader in scope than Trudeau.
• Fred Hutchinson Cancer Research Center: Major independent nonprofit biomedical research institute in Seattle with deep immunology and infectious disease expertise, particularly in HIV/AIDS and vaccine research. Comparable independent nonprofit research model and NIH funding dependence, though larger and broader in mission than Trudeau's focused infectious disease portfolio.
• Wyss Institute at Harvard University: Independent nonprofit biomedical research institute at Harvard focused on biologically inspired engineering and translational research in infectious disease and immunology. Comparable as a nonprofit research institute leveraging foundation and federal grants, though university-affiliated and substantially larger and broader than Trudeau.
• Battelle Memorial Institute: Largest independent nonprofit applied science and research organization, operating BSL-2/3 laboratories and providing CRO-like research services to government and commercial clients across infectious disease and biodefense. Comparable in operating BSL laboratories and serving federal agency clients, though vastly larger and broader in scope.

Direct peers

• Texas Biomedical Research Institute: Independent nonprofit biomedical research institute in San Antonio, Texas focused on infectious disease research including TB, with BSL-3/4 capabilities. Trudeau and Texas Biomed have an active research collaboration on Zika and dengue using marmoset models, making them directly comparable in mission, scale, and infrastructure.
• Lovelace Biomedical & Environmental Research Institute: Independent nonprofit biomedical research organization in Albuquerque, NM conducting preclinical research with BSL-2/3 capabilities across respiratory disease, infectious disease, and pulmonary toxicology. Comparable scale, nonprofit structure, and preclinical infectious disease research focus to Trudeau.
• MRIGlobal: Independent nonprofit contract research organization providing scientific research and technical services across infectious disease, biodefense, and pharmaceutical clients. Trudeau's Senior Study Director Shelton Bradrick previously led COVID and biodefense projects at MRIGlobal, and the organizations are comparable in CRO-like research service delivery model.
• Jackson Laboratory: Independent nonprofit biomedical research institution focused on mammalian genetics and human disease using mouse models, with 2,000+ employees and global operations. Comparable to Trudeau as a nonprofit research entity monetizing specialized mouse model expertise through both research and commercial services.
• Access to Advanced Health Institute (AAHI, formerly IDRI): Nonprofit biotech organization (formerly Infectious Disease Research Institute) focused on developing vaccines and immunotherapies for infectious diseases including TB and flaviviruses. Directly comparable mission, funding model (NIH + Gates Foundation grants), and translational research focus on global health.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Trudeau_Inst

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trudeau Institute